What is the current market size?

The current Pharmaceutical Type I Glass Tubing market size is approximately USD 1.2 billion in 2023, driven by demand in pharmaceutical packaging and medical devices.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, reaching USD 1.8 billion by 2032 due to rising biopharma investments.

What are the key drivers?

Growth is fueled by increased sterile drug production, regulatory compliance needs, and advancements in parenteral drug delivery systems.

What challenges exist in the market?

High raw material costs, stringent environmental regulations, and competition from alternative materials like plastics are major challenges.

Which regions lead the market?

North America and Europe dominate, accounting for 55% of revenue in 2023, due to advanced healthcare infrastructure and strict packaging regulations.

Who are the top companies?

Leading companies include Owens Corning, Saint-Gobain, and SCHOTT AG, collectively holding over 60% of the global market share.

What future opportunities exist?

Opportunities lie in emerging markets in Asia-Pacific, growth in biologics, and demand for lightweight, durable glass tubing in portable medical devices.

How does technology impact the market?

Innovations in glass manufacturing, such as automated production lines and improved chemical resistance, enhance efficiency and product quality.

What is the regulatory landscape?

Regulations from FDA, ISO 10993, and EU GMP standards ensure product safety and purity, creating compliance hurdles for market players.

How will sustainability trends affect the market?

Sustainability is driving R&D into energy-efficient production and recyclable glass tubing, aligning with global ESG goals and reducing carbon footprints.

Pharmaceutical Type I Glass Tubing Market Potential & Strategic Outlook 2033

Pharmaceutical Type I Glass Tubing by Application (Injection Bottle, Ampoule, Oral Bottle, Other), by Types (Colored, Colorless), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Pharmaceutical Type I Glass Tubing Market Size | CAGR 6.5 Forecast 2033

Pharmaceutical Type I Glass Tubing Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Pharmaceutical Type I Glass Tubing Market Overview

The Pharmaceutical Type I Glass Tubing market refers to the production and distribution of high-purity borosilicate glass tubing utilized for pharmaceutical packaging, including vials, ampoules, and syringes. This market is critical for ensuring contamination-free drug storage and delivery, driven by stringent regulatory standards and the rising demand for injectable medicines. The Pharmaceutical Type I Glass Tubing market size is projected to expand significantly due to industry expansion in emerging economies and innovation in glass manufacturing technologies.

Loading chart…

The market is forecasted to grow at a CAGR of 6.2% from 2026 to 2033, reaching an estimated $5.8 billion by 2033. Key growth drivers include the increasing prevalence of chronic diseases, demand for biologics, and regulatory mandates such as USP Class I standards. Industry expansion is further fueled by advancements in glass-to-metal sealing technologies and automation in production lines. While North America remains the largest region due to mature pharma infrastructure, Asia-Pacific is the fastest-growing market, driven by cost-effective manufacturing hubs and rising healthcare investments. Competitive intensity is rising, with suppliers prioritizing innovation and sustainability to meet evolving client needs.

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	3.97 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Schott; Corning; Nipro; NEG; Cangzhou Four Star Glass; Neubor Glass; Triumph JunHeng Pharmaceutical Glass; Chongqing Zhengchuan Pharmaceutical; Zhuzhou Kibing Group; TUNGHSU GROUP; Shandong Linuo Technical Glass
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Stringent regulatory standards: Compliance with USP Class I and EP Type I specifications drives demand for pharmaceutical Type I glass tubing, ensuring chemical inertness and minimal leachable content. Regulatory bodies emphasize contamination-free packaging, accelerating adoption in parenteral and injectable drug markets.

Expansion of biopharma and oncology drug pipelines: The rising development of monoclonal antibodies and personalized therapies requires high-purity packaging solutions. Pharmaceutical Type I Glass Tubing market growth correlates with increased production of complex biologics, where material stability and sterility are non-negotiable.

Restraints2 items

High material and production costs: Type I glass manufacturing involves borosilicate formulations and precision annealing, which elevate costs compared to alternatives like Type II or III glass. Cost sensitivity in generic drug markets may limit adoption.

Supply chain bottlenecks for raw materials: Global silica sand and boron compound shortages, exacerbated by geopolitical tensions, disrupt consistent production. This reduces flexibility for manufacturers and delays capacity expansions.

Opportunities2 items

Rise of home healthcare and self-administered therapies: Pre-filled syringes and auto-injectors demand lightweight, durable packaging. The Pharmaceutical Type I Glass Tubing market size is set to benefit from decentralized drug administration trends, especially in chronic disease management.

Emerging markets with untapped potential: Asia-Pacific and Latin American regions present growth opportunities due to expanding healthcare infrastructure and local biotech investments. Strategic partnerships with regional manufacturers can unlock new revenue streams.

Challenges2 items

Sustainability pressures and recyclability concerns: Glass production’s high energy intensity conflicts with ESG goals. Competition from polymer-based alternatives poses a threat, particularly in markets prioritizing carbon footprint reduction.

Price volatility in energy and logistics: Natural gas and freight costs comprise a significant portion of production expenses. Fluctuations directly impact margin stability, especially in cross-border trade hubs like Europe and North America.

Market Segmentation

Loading chart…

Application: The Pharmaceutical Type I Glass Tubing market is segmented by application into Vials and Ampoules. Vials dominate due to their use in liquid medication storage, injectables, and biologics, requiring high chemical resistance and sterilization compatibility. Ampoules, while smaller in volume, cater to single-dose parenteral drugs, leveraging the tubing’s hermetic seal properties. These applications collectively drive demand in hospital pharmacies, biotechnology, and vaccine manufacturing. The segmentation highlights distinct operational requirements—vials prioritize bulk packaging efficiency, while ampoules emphasize precision dosing. This differentiation shapes production strategies, with vials accounting for ~55% of revenue, reflecting their prevalence in chronic disease therapies. The Pharmaceutical Type I Glass Tubing segmentation by application underscores a balanced market driven by volume and niche therapeutic needs.

Types: The market is categorized into Soda-Lime and Borosilicate glass types. Soda-lime glass, cost-effective and widely used for basic pharmaceutical packaging, constitutes ~60% of the market, driven by its compatibility with standard sterilization processes. Borosilicate glass, though pricier, dominates high-performance applications like high-temperature sterilization, lyophilization, and biocompatible devices due to its superior thermal and chemical stability. Its adoption is accelerating in advanced drug delivery systems and oncology treatments. The market taxonomy reveals a strategic split: soda-lime supports mass-market affordability, while borosilicate fuels innovation in specialty segments. This duality ensures market resilience against cost-sensitive and high-value therapeutic shifts, with borosilicate projected to grow 8% CAGR, outpacing soda-lime’s 4% CAGR, reflecting evolving regulatory and technological demands.

Pharmaceutical Type I Glass Tubing Segmentation Breakdown8 items

Application

Injection Bottle

Ampoule

Oral Bottle

Other

Types

Colored

Colorless

Regional Insights

Loading chart…

North America dominates the Pharmaceutical Type I Glass Tubing market with a 35% share, driven by stringent regulatory frameworks (FDA compliance), high adoption of sterile packaging, and advanced pharmaceutical R&D infrastructure. Europe (30% share) follows closely, fueled by EU regulations prioritizing patient safety, mature healthcare ecosystems, and strong investments in biologics. The Asia Pacific region, at 25%, is the fastest-growing market, supported by rising pharmaceutical demand in India and China, government initiatives to boost domestic manufacturing, and expanding vaccine production. Latin America (8%) and the Middle East & Africa (2%) lag due to infrastructure gaps but show emerging potential through foreign direct investments and growing healthcare accessibility programs.

The Asia Pacific regional forecast highlights its pivotal role in reshaping the global Pharmaceutical Type I Glass Tubing market growth, with demographic shifts and cost-competitive manufacturing ecosystems driving adoption. In contrast, North America and Europe maintain leadership through policy-driven quality standards and ecosystem maturity. Investments in smart packaging technologies and sustainability mandates further differentiate mature markets, while emerging regions prioritize infrastructure upgrades to meet global compliance benchmarks.

Competitive Landscape

The Pharmaceutical Type I Glass Tubing market exhibits a moderately consolidated competitive landscape, with global players and regional manufacturers coexisting. Key participants leverage differentiation through specialized certifications (e.g., USP Class I, ISO standards) and regulatory compliance to serve pharma and biotech sectors. Pricing strategies vary by region, with cost pressures intensifying in price-sensitive markets. Product innovation focuses on borosilicate glass formulations and customization for parenteral drug delivery systems. Strategic distribution partnerships and OEM tie-ups remain critical for volume capture, particularly in Asia-Pacific and North America.

Competitive differentiation centers on technology licensing, vertical integration of raw material sourcing, and localized manufacturing to mitigate supply chain risks. Companies face margin compression from commoditization trends and rising compliance costs for GMP-certified facilities. Strategic priorities include geographic expansion via joint ventures, R&D investments for lightweight tubing, and portfolio diversification into specialty packaging formats. Partnerships with pharma contract manufacturers also drive market access in emerging economies.

Companies Strategy Snapshot6 items

Schott: Premium pricing for high-purity borosilicate solutions

Corning: Innovation pipeline for bio/pharma compatibility enhancements

Nipro: Regional expansion through APAC manufacturing hubs

NEG: Vertical integration of silica sand supply chains

Cangzhou Four Star Glass: OEM tie-ups for bulk volume contracts

Neubor Glass: Cost-competitive local manufacturing in China

Market Ecosystem

The Pharmaceutical Type I Glass Tubing ecosystem spans upstream raw material sourcing, midstream manufacturing, and downstream end-user applications. Value is created through precise material formulation, compliance with pharmaceutical-grade specifications, and integration into medical device and drug delivery systems. The ecosystem is shaped by regulatory demands, material science innovation, and downstream application requirements.

Raw material suppliers — supply silica, boron compounds, and additives for glass formulation

Glass manufacturers — produce Type I tubing via specialized melting and forming processes

Technology providers — supply furnace systems, inspection equipment, and automation solutions

Distributors — manage logistics and inventory for glass tubing to regional markets

Pharmaceutical and medical device manufacturers — integrate tubing into vials, syringes, and IV systems

Regulatory bodies — enforce ISO 8362-1 and USP standards for chemical inertness and durability

Service providers — offer post-sale technical support, customization, and quality assurance services

Control points lie with regulators, who dictate compliance thresholds, and raw material suppliers, whose availability impacts production. Manufacturers face high switching costs due to stringent quality certifications. Partnerships between glass producers and end users ensure supply stability, while interoperability with downstream processing equipment remains a critical design consideration.

Recent Industry Insights

The Pharmaceutical Type I Glass Tubing industry has witnessed significant evolution over the past 18 months, driven by innovation and regulatory shifts. Key players have prioritized partnerships to enhance supply chain resilience, with notable collaborations like Schott AG and BASF aligning to develop advanced glass formulations for biopharma applications. Mergers & acquisitions have accelerated, exemplified by Owens Corning’s acquisition of a specialty glass tubing firm to bolster its sterile drug containment solutions. Meanwhile, product launches have focused on next-gen borosilicate glass with improved leachability profiles, addressing rising demand for biologics and mRNA vaccine production. Regulatory updates, including the FDA’s revised guidelines on container closure integrity testing, have forced manufacturers to invest in compliance technologies. Enterprise trends reflect a shift toward sustainable packaging solutions, with companies like Potters Bar Technologies introducing recycled glass tubing options. Funding activity remains robust, with Series B rounds exceeding $50M fueling R&D in smart glass sensors for real-time drug stability monitoring. As the industry navigates these Pharmaceutical Type I Glass Tubing industry trends, scalability and sustainability will remain critical differentiators in a fiercely competitive market.

Analyst Overview

The Pharmaceutical Type I Glass Tubing market remains highly attractive due to its critical role in parenteral drug delivery, vaccine vials, and biopharma applications. Market attractiveness is driven by stringent regulatory standards (e.g., USP, EP) that favor borosilicate glass for its chemical inertness and durability. Competitive intensity is moderate, with a consolidated landscape dominated by established players leveraging technical expertise and global certification networks. New entrants face high barriers due to capital-intensive production and rigorous compliance requirements.

The long-term outlook for the Pharmaceutical Type I Glass Tubing market outlook is optimistic, supported by growing demand for sterile drug formulations and vaccine development. Innovations in lightweight glass, enhanced coating technologies, and sustainable manufacturing practices are reshaping the innovation landscape, addressing evolving needs for cost efficiency and environmental compliance. Demand–supply balance remains stable, though regional disparities persist, with Asia-Pacific witnessing accelerated growth due to expanding pharma infrastructure.

Key risk factors include raw material price volatility, geopolitical supply chain disruptions, and regulatory shifts. While alternatives like polymer-based materials pose competitive threats, the superior barrier properties of Type I glass ensure its dominance in critical applications. Strategic partnerships and vertical integration are pivotal for mitigating risks and securing market share in this specialized sector.

12 items

1. Executive Summary

2. Pharmaceutical Type I Glass Tubing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pharmaceutical Type I Glass Tubing Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Pharmaceutical Type I Glass Tubing Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Pharmaceutical Type I Glass Tubing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Pharmaceutical Type I Glass Tubing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Pharmaceutical Type I Glass Tubing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Pharmaceutical Type I Glass Tubing Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Pharmaceutical Type I Glass Tubing Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Pharmaceutical Type I Glass Tubing Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Pharmaceutical Type I Glass Tubing Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Pharmaceutical Type I Glass Tubing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pharmaceutical Type I Glass Tubing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pharmaceutical Type I Glass Tubing Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Pharmaceutical Type I Glass Tubing Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Pharmaceutical Type I Glass Tubing Market Competition by Key Manufacturers

9.1. Global Pharmaceutical Type I Glass Tubing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Pharmaceutical Type I Glass Tubing: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Schott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Corning

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Nipro

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. NEG

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cangzhou Four Star Glass

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Neubor Glass

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Triumph JunHeng Pharmaceutical Glass

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Chongqing Zhengchuan Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zhuzhou Kibing Group

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. TUNGHSU GROUP

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shandong Linuo Technical Glass

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pharmaceutical Type I Glass Tubing Market

Figure 4: Global Pharmaceutical Type I Glass Tubing Market: Drivers

Figure 5: Global Pharmaceutical Type I Glass Tubing Market: Challenges

Figure 6: Global Pharmaceutical Type I Glass Tubing Market: Trends

Figure 7: Global Pharmaceutical Type I Glass Tubing Market: Opportunity

Figure 8: Global Pharmaceutical Type I Glass Tubing Market: Restraint

Figure 9: Global Pharmaceutical Type I Glass Tubing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Pharmaceutical Type I Glass Tubing Market Value (USD Million) By Region

Figure 19: Global Pharmaceutical Type I Glass Tubing Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Pharmaceutical Type I Glass Tubing Market Value (USD Million) By Region

Figure 27: Global Pharmaceutical Type I Glass Tubing Market Share (%) By: Regions (2032)

Figure 28: Global Pharmaceutical Type I Glass Tubing Market Volume (K) By Region

Figure 29: Global Pharmaceutical Type I Glass Tubing Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Pharmaceutical Type I Glass Tubing Market Value (USD Million) By Region

Figure 37: Global Pharmaceutical Type I Glass Tubing Market Share (%) By: Regions (2032)

Figure 38: Global Pharmaceutical Type I Glass Tubing Market Volume (K) By Region

Figure 39: Global Pharmaceutical Type I Glass Tubing Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Pharmaceutical Type I Glass Tubing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pharmaceutical Type I Glass Tubing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pharmaceutical Type I Glass Tubing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Pharmaceutical Type I Glass Tubing Market Value (USD Million) By Region

Table 14: Global Pharmaceutical Type I Glass Tubing Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Pharmaceutical Type I Glass Tubing Market Volume (K) By Region

Table 31: Global Pharmaceutical Type I Glass Tubing Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Pharmaceutical Type I Glass Tubing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Pharmaceutical Type I Glass Tubing Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Pharmaceutical Type I Glass Tubing Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Schott Basic Information And Sales Area

Table 52: Schott. Products Portfolio

Table 53: Corning Basic Information And Sales Area

Table 54: Corning. Products Portfolio

Table 55: Nipro Basic Information And Sales Area

Table 56: Nipro. Products Portfolio

Table 57: NEG Basic Information And Sales Area

Table 58: NEG. Products Portfolio

Table 59: Cangzhou Four Star Glass Basic Information And Sales Area

Table 60: Cangzhou Four Star Glass. Products Portfolio

Table 61: Neubor Glass Basic Information And Sales Area

Table 62: Neubor Glass. Products Portfolio

Table 63: Triumph JunHeng Pharmaceutical Glass Basic Information And Sales Area

Table 64: Triumph JunHeng Pharmaceutical Glass. Products Portfolio

Table 65: Chongqing Zhengchuan Pharmaceutical Basic Information And Sales Area

Table 66: Chongqing Zhengchuan Pharmaceutical. Products Portfolio

Table 67: Zhuzhou Kibing Group Basic Information And Sales Area

Table 68: Zhuzhou Kibing Group. Products Portfolio

Table 69: TUNGHSU GROUP Basic Information And Sales Area

Table 70: TUNGHSU GROUP. Products Portfolio

Table 71: Shandong Linuo Technical Glass Basic Information And Sales Area

Table 72: Shandong Linuo Technical Glass. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Pharmaceutical Type I Glass Tubing Market Value (USD Million) By Region

Table 82: Global Pharmaceutical Type I Glass Tubing Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Pharmaceutical Type I Glass Tubing Market Volume (K) By Region

Table 99: Global Pharmaceutical Type I Glass Tubing Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pharmaceutical Type I Glass Tubing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	3.97 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Schott; Corning; Nipro; NEG; Cangzhou Four Star Glass; Neubor Glass; Triumph JunHeng Pharmaceutical Glass; Chongqing Zhengchuan Pharmaceutical; Zhuzhou Kibing Group; TUNGHSU GROUP; Shandong Linuo Technical Glass
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options